Dec 29, 2020, 01:00 AM by User Not Found

Bio-IT World | While much of the biotech and life sciences fields shifted to focus energy and efforts into understanding SARS-CoV-2 and the disease it causes, these weren’t the year’s only developments. This year Bio-IT World has covered growing data commons efforts, announced our annual Innovative Practices Award winners, looked at how Big Pharma is doing data science, delved into COVID-19 updates, and much more.

Dec 22, 2020, 01:00 AM by User Not Found

Bio-IT World | TRENDS FROM THE TRENCHES—We are routinely asked questions about Apache Airflow: when to use it, how to get the most out of it, and what to watch out for. Here’s why The BioTeam believes Apache Airflow is one of the most critical tools in the toolbox of a data scientist.

Dec 21, 2020, 01:00 AM by User Not Found

Bio-IT World | Funding updates around the life sciences including cash for a handheld mass spec device, Series D for oncolytic immunotherapy, a new company launch in allogenic CAR-NK cells, AI-powered cell classification, a 3-D sequencing platform, and more.

Dec 21, 2020, 01:00 AM by User Not Found

Bio-IT World | Immunai has announced its collaboration with 10x Genomics as one of the first 10x Certified Service Providers. Immunai will leverage 10x’s robust single-cell technologies to map hundreds of cell types and states. By applying its proprietary artificial intelligence and machine learning algorithms, Immunai supports biomarker discovery and insight generation to ultimately power new therapeutic discoveries and accelerate drug development.

Dec 18, 2020, 01:00 AM by User Not Found

Bio-IT World | Human “helper proteins” aiding the virus, genes linked with disease severity, the potency of neutralizing antibodies, and AI system identifying drugs. Plus: PacBio and Labcorp generate 65,000 genomes and funding from Germany and DARPA.

Dec 16, 2020, 15:54 PM by User Not Found

Bio-IT World | Emedgene has announced a non-exclusive partnership with Illumina and the integration of automated interpretation into Illumina's TruSight Software Suite for rare genetic diseases. Emedgene's Clinical Rare Disease application is one of a portfolio of artificial intelligence (AI)-powered applications for high-throughput genomic interpretation across clinical and research use cases.

Dec 16, 2020, 14:15 PM by

Dec 16, 2020, 14:15 PM by

Dec 16, 2020, 14:15 PM by

Specialist development pharmaceutical company AMZELL B.V has concluded discussions with the FDA ahead of initiating a Phase 3 trial of its new treatment for infantile epileptic disease, AMZ002.

Dec 16, 2020, 14:15 PM by

Dec 16, 2020, 14:15 PM by

Roambee’s technology solution for real-time logistics visibility has been proven to overcome many of the challenges of global COVID-19 vaccine distribution.

Dec 16, 2020, 14:15 PM by

Tribal Health will bridge the gap between brand promise and brand experience in healthcare for clients GSK, Gilead and Medela.

Dec 16, 2020, 14:15 PM by

Dec 16, 2020, 14:13 PM by

VERICHEM LABORATORIES now offers the TRU-ZERO™ BILIRUBIN STANDARD – a liquid stable, protein based, standard material intended for the AMR and calibration verification of Total and Direct bilirubin assays with a number of chemistry testing systems.

Dec 16, 2020, 14:13 PM by

Bailly Creat recently standardised on 530S peristaltic pumps from Watson-Marlow Fluid Technology Group for its lamination process.

Dec 16, 2020, 14:13 PM by

Dec 16, 2020, 14:13 PM by

Dec 16, 2020, 14:13 PM by

CluePoints, the premier provider of Central Statistical Monitoring, Risk-Based Quality Management and Data Quality Oversight Software for clinical trials, today announced further expansion in Japan with the opening of a new office in Tokyo. Dedicated to serving their Japanese clients, the new office builds on CluePoints’ presence in the region, as demand for modern analytical software and services enabling proactive and exhaustive identification of clinical study quality issues continues to grow. The new location, along with a team located in Osaka, will strengthen CluePoints’ growing reputation within Japan and bring it closer to its Asia-Pacific region customers.

Dec 16, 2020, 14:12 PM by

NanoSyrinx announces the appointment of Dr Jane Dancer to its Board as Non-Executive Director. Dr Dancer has over 30 years’ experience in business development across biotech, pharma and agrochemicals and her experience will help to drive NanoSyrinx’s ongoing fundraising activities and ambitious growth plans.

Dec 16, 2020, 14:12 PM by

THREAD, an innovative technology and service provider that enables decentralized clinical research, joins a formidable alliance of 50 life sciences and healthcare organizations to accelerate the broad adoption of patient-focused decentralized clinical trials and research.